News
Researchers studied trends in survival following FDA approval of immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback